IASLC

International Association for the Study of Lung Cancer

BARCELONA -- Adding a blood test to low-dose CT chest scans predicted lung cancer risk and mortality 4 years later and allowed lower-risk patients to lengthen the screening interval to 3 years, a large prospective study showed.

Accessibility Statement

At MedPage Today, we are committed to ensuring that individuals with disabilities can access all of the content offered by MedPage Today through our website and other properties. If you are having trouble accessing www.medpagetoday.com, MedPageToday's mobile apps, please email legal@ziffdavis.com for assistance. Please put "ADA Inquiry" in the subject line of your email.